Cascades

Bear Island Efficiencies And Tissue Demand Will Support Stronger Long Term Profitability

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

08 Dec 25

Views

n/a

AnalystConsensusTarget's Fair Value

n/a

7.7%

2.2%

7.7%

2.2%

You can edit this narrative until Dec 9 8:05 PM. Then, changes will post as Updates.

Author's Valuation

CA$13.337.4% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

CA$13.33

7.4% undervalued

Future estimation in

Growth p.a.

Decrease

Increase

Current revenue growth rate

0.29%

Packaging revenue growth rate

0.15%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.07%

Calculation

CA$624.29m

Earnings '28

2.18x

PE Ratio '28

CA$1.36b

Market Cap '28

CA$1.36b

Market Cap '28

102.05m

No. shares '28

CA$13.37

Share Price '28

CA$13.37 Share Price '28

Discounted to 2025 @ 0.08% p.a.

CA$13.33

Fair Value '25